Taiwan Pemetrexed Market Size & Outlook, 2025-2033


Taiwan Pemetrexed Market Insights

  • According to Reed Intelligence analysis, the Taiwan Pemetrexed Market size was USD 24.54 Million in 2024 and is projected to reach USD 28.37 Million by 2033.
  • The Taiwan market is projected to grow at a CAGR of 1.64% between 2026 and 2033.
  • By segment, Malignant Pleural Mesothelioma emerged as the largest By Application in terms of market size in 2024.
  • Non-Squamous NSCLC is anticipated to remain the most attractive By Application segment, recording the fastest growth during the forecast period.

Other Key Findings


  • Taiwan accounted for 1.05% of the global Pemetrexed Market size in 2024.
  • By 2033, United States is expected to remain the top global market in terms of size.
  • Within Asia Pacific, China is forecasted to dominate the regional Pemetrexed Market size by 2033.
  • India will be the fastest-growing market in Asia Pacific, projected to achieve USD 94.95 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 24.54 Million
Market Size In 2033 USD 28.37 Million
Largest segment Malignant Pleural Mesothelioma
Units Revenue in USD Million
CAGR 1.64% (2025-2033)
Segmnetation Covered
By Application
  1. Malignant Pleural Mesothelioma
  2. Non-Squamous NSCLC
By End-User
  1. Hospitals
  2. Oncology Centers
  3. Online Pharmacies
  4. Offline Pharmacies
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends